Welcome to Helix Talk, a podcast presented by the Rosalind Franklin University College of Pharmacy.

We're hoping that our real-life clinical pearls and discussions will help you stay up to date and improve your pharmacy knowledge.

This podcast contains general information for educational purposes only. This is

not professional advice and should not be used in lieu of obtaining advice from a qualified

health care provider. And now, on to the show. Welcome to episode 34 of Helix Talk. I'm your

co-host, Dr. Keane. I'm Dr. Schumann. And I'm Dr. Patel. And this week we're talking about some newly approved insulin products that have just

made it to the market.

So namely we're going to be talking about Tujao, that's Glorging U-300, Humologue-200,

and very recently approved Daglodec, which is available as U-100 as U-200.

Remember, Friza is also a new insulin, but we've talked about it already in episode 16.

Dr. Patel, when you say U-100, U-200 and U-300, what do the numbers mean?

Basically, these are the strengths of your insulin. So that basically means that there

are 300 units of insulin per 1ML of this 2JO. Same thing with Humilog, there is 200 units per 1ML,

versus the traditional ones, the U100100 is 100 units per 1ML.

So you're talking about a little stronger insulin, if you would say so.

So then most of the insulin's on the market before these guys came out, almost all of them

were U-100, right?

That is correct.

Besides the fact that regular insulin was available as U-500 to begin with, but now you're going to be seeing all these new strains because the original U-100,

either it's near to its patent expiration or manufacturers done making money and they want to make

money on the new prototype.

Yeah, I was about to ask you what the reason was for, but it sounds like you answered

...